Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers?

J Cell Physiol. 2018 Jun;233(6):4595-4605. doi: 10.1002/jcp.26313. Epub 2018 Jan 15.

Abstract

Wnt signaling is an evolutionary highly conserved pathway that is modulated by several inhibitors and activators, and plays a key role in numerous physiological processes. One of the extracellular Wnt inhibitors is the DKK (Dickkopf Homolog) family which has four members (Dkk1-4) and a unique Dkk3-related gene, Dkkl1 (soggy). DKK3 is a divergent member of the DKK protein family. Evidence suggests that DKK3 may serve as a potential therapeutic target in several types of human cancers. We review here the biological role of DKK3 as a tumor suppressor gene (TSG) or oncogene, and its correlation with various miRNAs. In addition, we discuss the role of polymorphisms and promoter methylation of the DKK3 gene, and of its expression in regulating cancer cell proliferation. Finally, we propose that DKK3 may be considered as both a biomarker and a therapeutic target in different cancers.

Keywords: Dickkopf-related protein 3 (DKK3); Wnt pathway; biomarker; cancer therapeutics.

Publication types

  • Review

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Animals
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • Cell Proliferation*
  • Chemokines
  • DNA Methylation
  • Gene Expression Regulation, Neoplastic
  • Genetic Therapy / methods
  • Humans
  • Intercellular Signaling Peptides and Proteins / genetics
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Polymorphism, Genetic
  • Promoter Regions, Genetic
  • Wnt Signaling Pathway

Substances

  • Adaptor Proteins, Signal Transducing
  • Biomarkers, Tumor
  • Chemokines
  • DKK3 protein, human
  • Intercellular Signaling Peptides and Proteins